5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure


 

Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testing in DCIS, Centromeric Probes, PDL-1 in TNBC, Changes in Fish Ratio & Heterogeneous HER2

210 views
September 17, 2019
Comments 0
Login to view comments. Click here to Login